🇺🇸 FDA
Patent

US 7892777

Methods for measuring whether a treatment affects RPTP-κ activity

granted A61KA61K36/03A61K8/9711

Quick answer

US patent 7892777 (Methods for measuring whether a treatment affects RPTP-κ activity) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K36/03, A61K8/9711, A61P, A61P17/00